Tenon Medical, Inc. Announces Timing of Second Quarter 2025 Financial Results
Tenon Medical (NASDAQ:TNON), a company focused on Sacroiliac Joint (SIJ) disorders treatment, will release its Q2 2025 financial results after market close on Wednesday, August 13, 2025.
The company will host a conference call at 4:30 p.m. Eastern Time on the same day, featuring a Q&A session with covering analysts. The call will be accessible via telephone and webcast, with replay available through August 27, 2025 on Tenon's Investor Relations website.
Tenon Medical (NASDAQ:TNON), azienda specializzata nel trattamento dei disturbi dell'articolazione sacroiliaca (SIJ), pubblicherà i suoi risultati finanziari del secondo trimestre 2025 dopo la chiusura del mercato di mercoledì 13 agosto 2025.
La società terrà una conference call alle 16:30 ora della costa orientale dello stesso giorno, con una sessione di domande e risposte con gli analisti. La chiamata sarà accessibile via telefono e webcast, con la possibilità di riascolto disponibile fino al 27 agosto 2025 sul sito web delle Relazioni con gli Investitori di Tenon.
Tenon Medical (NASDAQ:TNON), una empresa enfocada en el tratamiento de trastornos de la articulación sacroilíaca (SIJ), publicará sus resultados financieros del segundo trimestre de 2025 después del cierre del mercado el miércoles 13 de agosto de 2025.
La compañía realizará una llamada conferencia a las 4:30 p.m. hora del Este ese mismo día, con una sesión de preguntas y respuestas con los analistas. La llamada será accesible por teléfono y webcast, con repetición disponible hasta el 27 de agosto de 2025 en el sitio web de Relaciones con Inversionistas de Tenon.
테논 메디컬 (NASDAQ:TNON)은 천장관절(SIJ) 질환 치료에 주력하는 회사로, 2025년 2분기 재무 결과를 2025년 8월 13일 수요일 장 마감 후 발표할 예정입니다.
회사는 같은 날 동부 표준시 오후 4시 30분에 컨퍼런스 콜을 진행하며, 애널리스트와의 질의응답 세션이 포함됩니다. 이 콜은 전화 및 웹캐스트로 참여할 수 있으며, 2025년 8월 27일까지 테논 투자자 관계 웹사이트에서 다시 듣기가 가능합니다.
Tenon Medical (NASDAQ:TNON), une société spécialisée dans le traitement des troubles de l'articulation sacro-iliaque (SIJ), publiera ses résultats financiers du deuxième trimestre 2025 après la clôture du marché le mercredi 13 août 2025.
La société organisera une conférence téléphonique à 16h30, heure de l'Est le même jour, comprenant une session de questions-réponses avec les analystes. L'appel sera accessible par téléphone et webcast, avec une rediffusion disponible jusqu'au 27 août 2025 sur le site des relations investisseurs de Tenon.
Tenon Medical (NASDAQ:TNON), ein Unternehmen, das sich auf die Behandlung von Sakroiliakalgelenksstörungen (SIJ) spezialisiert hat, wird seine Finanzergebnisse für das zweite Quartal 2025 nach Börsenschluss am Mittwoch, den 13. August 2025 veröffentlichen.
Das Unternehmen wird am selben Tag um 16:30 Uhr Eastern Time eine Telefonkonferenz mit einer Fragerunde für Analysten abhalten. Der Anruf ist telefonisch und per Webcast zugänglich, mit einer Wiedergabeoption bis zum 27. August 2025 auf der Investor-Relations-Website von Tenon.
- None.
- None.
LOS GATOS, CA / ACCESS Newswire / August 5, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering from certain Sacroiliac Joint (SIJ) disorders, today announced plans to release financial results for the second quarter 2025 ended June 30, 2025 after market close on Wednesday, August 13, 2025. The Company will also hold a conference call on the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with its covering analysts.
Date: | Wednesday, August 13, 2025 |
Time: | 4:30 p.m. Eastern time |
Dial-in: | 1-877-407-0792 |
International Dial-in: | 1-201-689-8263 |
Webcast: |
Please dial in at least 10 minutes before the start of the call to ensure timely participation.
An audio playback of the call will be available through August 27, 2025, on Tenon's Investor Relations website at http://ir.tenonmed.com/ or via telephone replay by dialing 1-844-512-2921 (USA) or 1-412-317-6671 (International). The access code will be 13754961.
About Tenon Medical, Inc.
Tenon Medical, Inc., a medical device company formed in 2012, has developed The Catamaran SI Joint Fusion System that offers a novel, less invasive approach to the SI joint using a single, robust titanium implant. The system features the Catamaran™ Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, stabilizing and transfixing the SI Joint along its longitudinal axis. The angle and trajectory of the Catamaran surgical approach is also designed to provide a pathway away from critical neural and vascular structures and into the strongest cortical bone. Since the national launch of the Catamaran SI Joint Fusion System in October 2022, Tenon is focused on three commercial opportunities with its System in the SI Joint market which includes: 1) Primary SI Joint procedures, 2) Revision procedures of failed SI Joint implants and 3) SI Joint fusion adjunct to a spine fusion construct. For more information, please visit www.tenonmed.com.
The Tenon Medical logo shown above, and Catamaran®, PiSIF®, CAT PiSIF®, ETAD®, Posterior Inferior Sacroiliac Fusion®, CAT SIJ Fusion System®, Catamaran SIJ Fusion System®, Catamaran Inferior Posterior Fusion System®, Catamaran Transfixation Fusion System®, and Catamaran Transfixation Fusion Device® are registered trademarks of Tenon Medical, Inc. MAINSAILTM is also a trademark of Tenon Medical, Inc.
Investor Contact
Shannon Devine
MZ North America
203-741-8811
tenon@mzgroup.us
SOURCE: Tenon Medical, Inc.
View the original press release on ACCESS Newswire
FAQ
When will Tenon Medical (TNON) release Q2 2025 earnings?
How can investors join Tenon Medical's Q2 2025 earnings call?
How long will Tenon Medical's Q2 2025 earnings call replay be available?
What does Tenon Medical (TNON) specialize in?
